Breadcrumbs

Main page content

Search all documents

Recently Added Publications

Title Published Date Office File(s) Page
WCI/UCI Rates - FY 2020 Risk Management WCI/UCI Rates - FY 2020 More Info on WCI/UCI Rates - FY 2020
Appendix D-WCI/UCI Premium Due Dates Risk Management 2020 Premium Due Dates More Info on Appendix D-WCI/UCI Premium Due Dates
IMO Med-Select HCN Employee Handbook Risk Management English
Español
More Info on IMO Med-Select HCN Employee Handbook
IMO Med-Select HCN Notice of Network Requirements Risk Management English
Español
More Info on IMO Med-Select HCN Notice of Network Requirements
Full Time Equivalent Employee Report: FY 2020 Budget and Planning 1st Quarter FY 2020
2nd Quarter FY 2020
More Info on Full Time Equivalent Employee Report: FY 2020
IMO Med-Select HCN Employee Handbook - Vietnamese Risk Management Vietnamese More Info on IMO Med-Select HCN Employee Handbook - Vietnamese
IMO Med-Select HCN Notice of Network Requirements - Vietnamese Risk Management Vietnamese More Info on IMO Med-Select HCN Notice of Network Requirements - Vietnamese
UTRGV Bursar's Office Report System Audit UTRGV Bursar's Office Report More Info on UTRGV Bursar's Office Report
Memorandum of Understanding-Investment Related Transactions & Account: FY 2020 Controller February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
More Info on Memorandum of Understanding-Investment Related Transactions & Account: FY 2020
Procurement - Summary of Purchase Orders Controller PO Summary Report: 9-1-2015 thru 3-18-2020 More Info on Procurement - Summary of Purchase Orders
Abbott Laboratories General Counsel Abbott Laboratories - Universal Sponsored Clinical Study Agreement Template
Abbott Laboratories - Universal Sponsored Clinical Study Agreement Template - Pharmaceuticals - 5/9/1994
Abbott Laboratories – Amended and Restated Master Clinical Study Agreement – Abbott Initiated – (Eff. 3/26/2012 - 3/26/2019)
Abbott Laboratories - Amended and Restated Master Clinical Study Agreement - Abbott Initiated - Amendment #1 (Effective 3/26/19)
Abbott Laboratories - Amended and Restated Master Clinical Study Agreement - Abbott Initiated - Amendment #2 (Eff. 1/1/2020)
Abbott Laboratories - Master Clinical Study Agreement - Abbott Initiated - 12/7/2006
Abbott Laboratories - Master Clinical Study Agreement - Abbott Initiated - Amendment #1 (Effective 7/29/2009)
More Info on Abbott Laboratories
Astellas Pharma US, Inc. General Counsel Astellas Pharma US, Inc. - Master Clinical Study Agreement - 4/18/2007
Amendment #1 (effective 4/17/2012)
Astellas Pharma Global Development, Inc. – Amended and Restated Master Clinical Study Agreement – 4/18/2014
Amendment #1 - 1/28/2020
More Info on Astellas Pharma US, Inc.
UTMDACC Perioperative Services Division Report System Audit UTMDACC Perioperative Services Division Report More Info on UTMDACC Perioperative Services Division Report
UTHSCT Accounts Payable Report System Audit UTHSCT Accounts Payable Report More Info on UTHSCT Accounts Payable Report
Monthly Financial Report: FY 2020 Controller Jan 2020
Dec 2019
Nov 2019
More Info on Monthly Financial Report: FY 2020